Technology Today News Gene Editing Technology Is Revolutionizing Disease Treatment The Excerpt
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Technology Today News Gene Editing Technology Is Revolutionizing Disease Treatment The Excerpt is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Baby KJ’s doctors will ask FDA this winter to OK a clinical trial of pioneering gene editing approach
Baby KJ's medical team intend to ask the FDA to start a clinical trial that would be open to patients with seven different urea cycle disorders. Read More
The quest to create gene-edited babies gets a reboot
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies. His work was reviled as reckless and unethical because, ... Read More
Customized gene-editing technology shows potential to treat lethal pediatric disease
Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently, there is no effective treatment or ... Read More
Gene editing therapy exa-cel improves quality of life in sickle cell disease and beta thalassemia
"This is the first time we've been able to measure improvements in quality of life after treatment with gene editing technology," said Josu de la Fuente, PhD, director of the Paediatric Blood and ... Read More
High-Precision Base Editing Clinical Treatment for Sickle Cell Disease — CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the ... Read More
Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease
U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), a fatal ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus